Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9

Efficient methodologies for recreating cancer-associated chromosome translocations are in high demand as tools for investigating how such events initiate cancer. The CRISPR/Cas9 system has been used to reconstruct the genetics of these complex rearrangements at native loci while maintaining the arch...

Full description

Bibliographic Details
Main Authors: Raul Torres-Ruiz, Marta Martinez-Lage, Maria C. Martin, Aida Garcia, Clara Bueno, Julio Castaño, Juan C. Ramirez, Pablo Menendez, Juan C. Cigudosa, Sandra Rodriguez-Perales
Format: Article
Language:English
Published: Elsevier 2017-05-01
Series:Stem Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213671117301686
_version_ 1818317144384864256
author Raul Torres-Ruiz
Marta Martinez-Lage
Maria C. Martin
Aida Garcia
Clara Bueno
Julio Castaño
Juan C. Ramirez
Pablo Menendez
Juan C. Cigudosa
Sandra Rodriguez-Perales
author_facet Raul Torres-Ruiz
Marta Martinez-Lage
Maria C. Martin
Aida Garcia
Clara Bueno
Julio Castaño
Juan C. Ramirez
Pablo Menendez
Juan C. Cigudosa
Sandra Rodriguez-Perales
author_sort Raul Torres-Ruiz
collection DOAJ
description Efficient methodologies for recreating cancer-associated chromosome translocations are in high demand as tools for investigating how such events initiate cancer. The CRISPR/Cas9 system has been used to reconstruct the genetics of these complex rearrangements at native loci while maintaining the architecture and regulatory elements. However, the CRISPR system remains inefficient in human stem cells. Here, we compared three strategies aimed at enhancing the efficiency of the CRISPR-mediated t(11;22) translocation in human stem cells, including mesenchymal and induced pluripotent stem cells: (1) using end-joining DNA processing factors involved in repair mechanisms, or (2) ssODNs to guide the ligation of the double-strand break ends generated by CRISPR/Cas9; and (3) all-in-one plasmid or ribonucleoprotein complex-based approaches. We report that the generation of targeted t(11;22) is significantly increased by using a combination of ribonucleoprotein complexes and ssODNs. The CRISPR/Cas9-mediated generation of targeted t(11;22) in human stem cells opens up new avenues in modeling Ewing sarcoma.
first_indexed 2024-12-13T09:32:39Z
format Article
id doaj.art-780919482ffd49d4a410c727e962bb2a
institution Directory Open Access Journal
issn 2213-6711
language English
last_indexed 2024-12-13T09:32:39Z
publishDate 2017-05-01
publisher Elsevier
record_format Article
series Stem Cell Reports
spelling doaj.art-780919482ffd49d4a410c727e962bb2a2022-12-21T23:52:26ZengElsevierStem Cell Reports2213-67112017-05-01851408142010.1016/j.stemcr.2017.04.014Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9Raul Torres-Ruiz0Marta Martinez-Lage1Maria C. Martin2Aida Garcia3Clara Bueno4Julio Castaño5Juan C. Ramirez6Pablo Menendez7Juan C. Cigudosa8Sandra Rodriguez-Perales9Molecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, SpainMolecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, SpainMolecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, SpainHematopoietic Innovative Therapies Division, Centro Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)-Centro Investigaciones Biomédicas Red Enfermedades Raras (CIBERER), Madrid 28040, SpainDepartment of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona 08036, SpainDepartment of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona 08036, SpainVIVEBioTECH, San Sebastian 20009, SpainDepartment of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona 08036, SpainMolecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, SpainMolecular Cytogenetics Group, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid 28029, SpainEfficient methodologies for recreating cancer-associated chromosome translocations are in high demand as tools for investigating how such events initiate cancer. The CRISPR/Cas9 system has been used to reconstruct the genetics of these complex rearrangements at native loci while maintaining the architecture and regulatory elements. However, the CRISPR system remains inefficient in human stem cells. Here, we compared three strategies aimed at enhancing the efficiency of the CRISPR-mediated t(11;22) translocation in human stem cells, including mesenchymal and induced pluripotent stem cells: (1) using end-joining DNA processing factors involved in repair mechanisms, or (2) ssODNs to guide the ligation of the double-strand break ends generated by CRISPR/Cas9; and (3) all-in-one plasmid or ribonucleoprotein complex-based approaches. We report that the generation of targeted t(11;22) is significantly increased by using a combination of ribonucleoprotein complexes and ssODNs. The CRISPR/Cas9-mediated generation of targeted t(11;22) in human stem cells opens up new avenues in modeling Ewing sarcoma.http://www.sciencedirect.com/science/article/pii/S2213671117301686CRISPRcancer translocationhuman stem cellsgenome engineeringEwing sarcomaMSCiPSCcancer modelingCas9disease model
spellingShingle Raul Torres-Ruiz
Marta Martinez-Lage
Maria C. Martin
Aida Garcia
Clara Bueno
Julio Castaño
Juan C. Ramirez
Pablo Menendez
Juan C. Cigudosa
Sandra Rodriguez-Perales
Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
Stem Cell Reports
CRISPR
cancer translocation
human stem cells
genome engineering
Ewing sarcoma
MSC
iPSC
cancer modeling
Cas9
disease model
title Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
title_full Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
title_fullStr Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
title_full_unstemmed Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
title_short Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
title_sort efficient recreation of t 11 22 ewsr1 fli1 in human stem cells using crispr cas9
topic CRISPR
cancer translocation
human stem cells
genome engineering
Ewing sarcoma
MSC
iPSC
cancer modeling
Cas9
disease model
url http://www.sciencedirect.com/science/article/pii/S2213671117301686
work_keys_str_mv AT raultorresruiz efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT martamartinezlage efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT mariacmartin efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT aidagarcia efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT clarabueno efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT juliocastano efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT juancramirez efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT pablomenendez efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT juanccigudosa efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9
AT sandrarodriguezperales efficientrecreationoft1122ewsr1fli1inhumanstemcellsusingcrisprcas9